Rank | Gene Set | Z-score |
---|---|---|
1 | axon ensheathment in central nervous system (GO:0032291) | 6.22161182 |
2 | central nervous system myelination (GO:0022010) | 6.22161182 |
3 | histone H3-K4 trimethylation (GO:0080182) | 5.29471334 |
4 | interleukin-6-mediated signaling pathway (GO:0070102) | 4.94965746 |
5 | neuron cell-cell adhesion (GO:0007158) | 4.49075594 |
6 | L-amino acid import (GO:0043092) | 4.43779103 |
7 | negative regulation of cell killing (GO:0031342) | 4.39832104 |
8 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 4.39832104 |
9 | locomotory exploration behavior (GO:0035641) | 4.37848207 |
10 | synaptic vesicle maturation (GO:0016188) | 4.32773177 |
11 | regulation of B cell receptor signaling pathway (GO:0050855) | 4.24051014 |
12 | ensheathment of neurons (GO:0007272) | 4.16973585 |
13 | axon ensheathment (GO:0008366) | 4.16973585 |
14 | myelination (GO:0042552) | 4.16967422 |
15 | positive regulation of gamma-delta T cell activation (GO:0046645) | 4.04527973 |
16 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.87744235 |
17 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.87744235 |
18 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.87744235 |
19 | modulation by symbiont of host immune response (GO:0052553) | 3.87744235 |
20 | positive regulation by symbiont of host defense response (GO:0052509) | 3.87744235 |
21 | modulation by symbiont of host defense response (GO:0052031) | 3.87744235 |
22 | epithelial cell fate commitment (GO:0072148) | 3.78305486 |
23 | fatty acid elongation (GO:0030497) | 3.76657574 |
24 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 3.71343806 |
25 | synaptic vesicle exocytosis (GO:0016079) | 3.70960784 |
26 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.69102813 |
27 | peptidyl-lysine trimethylation (GO:0018023) | 3.61108534 |
28 | long-chain fatty acid biosynthetic process (GO:0042759) | 3.60008807 |
29 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 3.57234425 |
30 | presynaptic membrane assembly (GO:0097105) | 3.54746030 |
31 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 3.52792960 |
32 | neuronal action potential propagation (GO:0019227) | 3.51660025 |
33 | negative regulation of neurotransmitter transport (GO:0051589) | 3.50410329 |
34 | presynaptic membrane organization (GO:0097090) | 3.48647548 |
35 | regulation of synaptic vesicle exocytosis (GO:2000300) | 3.45244242 |
36 | transmission of nerve impulse (GO:0019226) | 3.43750434 |
37 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 3.43066725 |
38 | macrophage activation involved in immune response (GO:0002281) | 3.42436403 |
39 | glutamate secretion (GO:0014047) | 3.40939293 |
40 | amino acid import (GO:0043090) | 3.38354110 |
41 | neutrophil activation involved in immune response (GO:0002283) | 3.37862315 |
42 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 3.36365401 |
43 | microglial cell activation (GO:0001774) | 3.34384983 |
44 | myelin maintenance (GO:0043217) | 3.33853419 |
45 | protein targeting to Golgi (GO:0000042) | 3.33398068 |
46 | adult walking behavior (GO:0007628) | 3.32884343 |
47 | negative regulation of neurotransmitter secretion (GO:0046929) | 3.32465666 |
48 | dendritic spine morphogenesis (GO:0060997) | 3.32293925 |
49 | negative regulation of interleukin-17 production (GO:0032700) | 3.32183696 |
50 | B cell receptor signaling pathway (GO:0050853) | 3.29498413 |
51 | establishment of protein localization to Golgi (GO:0072600) | 3.22211207 |
52 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.21342932 |
53 | regulation of cell maturation (GO:1903429) | 3.20372805 |
54 | vocalization behavior (GO:0071625) | 3.16640843 |
55 | retrograde transport, vesicle recycling within Golgi (GO:0000301) | 3.16555804 |
56 | cellular extravasation (GO:0045123) | 3.15327320 |
57 | activated T cell proliferation (GO:0050798) | 3.13803360 |
58 | positive thymic T cell selection (GO:0045059) | 3.10295882 |
59 | mating behavior (GO:0007617) | 3.09109120 |
60 | detection of molecule of bacterial origin (GO:0032490) | 3.07915534 |
61 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.06355355 |
62 | response to methylmercury (GO:0051597) | 3.03059622 |
63 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.02411321 |
64 | gamma-aminobutyric acid transport (GO:0015812) | 3.00238791 |
65 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.99550595 |
66 | neutrophil mediated immunity (GO:0002446) | 2.98333031 |
67 | positive T cell selection (GO:0043368) | 2.98187877 |
68 | exploration behavior (GO:0035640) | 2.97784075 |
69 | regulation of neuronal synaptic plasticity (GO:0048168) | 2.96706208 |
70 | regulation of glutamate receptor signaling pathway (GO:1900449) | 2.96540318 |
71 | cellular response to ethanol (GO:0071361) | 2.95566902 |
72 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 2.94656236 |
73 | glutamate receptor signaling pathway (GO:0007215) | 2.94593493 |
74 | detection of other organism (GO:0098543) | 2.93711950 |
75 | nerve growth factor signaling pathway (GO:0038180) | 2.93152619 |
76 | neurotransmitter-gated ion channel clustering (GO:0072578) | 2.92115215 |
77 | regulation of beta-amyloid formation (GO:1902003) | 2.91571998 |
78 | protein localization to synapse (GO:0035418) | 2.90903558 |
79 | negative regulation of peptidyl-threonine phosphorylation (GO:0010801) | 2.89527742 |
80 | myeloid leukocyte mediated immunity (GO:0002444) | 2.89242973 |
81 | centrosome localization (GO:0051642) | 2.88815826 |
82 | dendrite morphogenesis (GO:0048813) | 2.88803467 |
83 | glycerophospholipid catabolic process (GO:0046475) | 2.88697519 |
84 | phosphatidylinositol-3-phosphate biosynthetic process (GO:0036092) | 2.87607442 |
85 | regulation of synaptic vesicle transport (GO:1902803) | 2.86095498 |
86 | neurotransmitter secretion (GO:0007269) | 2.85349717 |
87 | cerebellar granule cell differentiation (GO:0021707) | 2.84624581 |
88 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 2.84397812 |
89 | clathrin coat assembly (GO:0048268) | 2.83474766 |
90 | glycine transport (GO:0015816) | 2.83095612 |
91 | regulation of amyloid precursor protein catabolic process (GO:1902991) | 2.82802725 |
92 | positive regulation of oligodendrocyte differentiation (GO:0048714) | 2.82146030 |
93 | neuronal ion channel clustering (GO:0045161) | 2.81959411 |
94 | macrophage activation (GO:0042116) | 2.81811838 |
95 | oligodendrocyte differentiation (GO:0048709) | 2.81346964 |
96 | positive regulation of toll-like receptor signaling pathway (GO:0034123) | 2.81306054 |
97 | neuron recognition (GO:0008038) | 2.80515516 |
98 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 2.80006004 |
99 | regulation of collateral sprouting (GO:0048670) | 2.79882396 |
100 | establishment of mitochondrion localization (GO:0051654) | 2.79871839 |
101 | negative thymic T cell selection (GO:0045060) | 2.79648186 |
102 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 2.79389613 |
103 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 2.79247278 |
104 | positive regulation of histone H3-K4 methylation (GO:0051571) | 2.79196464 |
105 | long-term synaptic potentiation (GO:0060291) | 2.78798738 |
106 | defense response to protozoan (GO:0042832) | 2.78531211 |
107 | regulation of gamma-delta T cell activation (GO:0046643) | 2.77765490 |
108 | regulation of B cell differentiation (GO:0045577) | 2.76794734 |
109 | protein localization to microtubule cytoskeleton (GO:0072698) | 2.75922160 |
110 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 2.75586805 |
111 | histone H3-K4 methylation (GO:0051568) | 2.74826786 |
112 | negative regulation of axonogenesis (GO:0050771) | 2.74638544 |
113 | negative T cell selection (GO:0043383) | 2.71442349 |
114 | neuron-neuron synaptic transmission (GO:0007270) | 2.70615378 |
115 | detection of external biotic stimulus (GO:0098581) | 2.69587039 |
116 | regulation of fibroblast apoptotic process (GO:2000269) | 2.68692299 |
117 | positive regulation of membrane potential (GO:0045838) | 2.67649887 |
118 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 2.67466620 |
119 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 2.67400532 |
120 | regulation of synapse structural plasticity (GO:0051823) | 2.66593137 |
121 | neutrophil activation (GO:0042119) | 2.65838312 |
122 | synaptic transmission, glutamatergic (GO:0035249) | 2.65619297 |
123 | negative regulation of fibroblast apoptotic process (GO:2000270) | 2.65407087 |
124 | peptidyl-tyrosine autophosphorylation (GO:0038083) | 2.64593321 |
125 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 2.63478712 |
126 | neurotransmitter transport (GO:0006836) | 2.62285308 |
127 | positive regulation of Rap GTPase activity (GO:0032854) | 2.62042603 |
128 | vesicle transport along microtubule (GO:0047496) | 2.61711677 |
129 | regulation of ARF protein signal transduction (GO:0032012) | 2.60682239 |
130 | immunoglobulin mediated immune response (GO:0016064) | 2.60306227 |
131 | long-term memory (GO:0007616) | 2.60211803 |
132 | cell wall macromolecule catabolic process (GO:0016998) | 2.59611218 |
133 | positive regulation of B cell differentiation (GO:0045579) | 2.58899560 |
134 | prepulse inhibition (GO:0060134) | 2.58359774 |
135 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.57519827 |
136 | response to host immune response (GO:0052572) | 2.57519827 |
137 | negative regulation of granulocyte differentiation (GO:0030853) | 2.57488578 |
138 | regulation of granulocyte differentiation (GO:0030852) | 2.57204986 |
139 | regulation of gamma-delta T cell differentiation (GO:0045586) | 2.56709922 |
140 | myeloid cell activation involved in immune response (GO:0002275) | 2.56399729 |
141 | neuromuscular process controlling balance (GO:0050885) | 2.55625104 |
142 | regulation of gene expression by genetic imprinting (GO:0006349) | 2.54758488 |
143 | detection of bacterium (GO:0016045) | 2.54675822 |
144 | axonal fasciculation (GO:0007413) | 2.53220024 |
145 | regulation of synaptic plasticity (GO:0048167) | 2.52001155 |
146 | substantia nigra development (GO:0021762) | 2.51894666 |
147 | layer formation in cerebral cortex (GO:0021819) | 2.51847658 |
148 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 2.51345685 |
149 | neuron fate determination (GO:0048664) | 2.50389126 |
150 | I-kappaB phosphorylation (GO:0007252) | 2.49894210 |
151 | regulation of voltage-gated calcium channel activity (GO:1901385) | 2.49471176 |
152 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 2.48471420 |
153 | interkinetic nuclear migration (GO:0022027) | 2.48072160 |
154 | organelle transport along microtubule (GO:0072384) | 2.47385953 |
155 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 2.47224076 |
156 | L-glutamate transport (GO:0015813) | 2.47120252 |
157 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.47097197 |
158 | regulation of acrosome reaction (GO:0060046) | 2.47095588 |
159 | amyloid precursor protein metabolic process (GO:0042982) | 2.46986153 |
160 | synaptic vesicle endocytosis (GO:0048488) | 2.46847420 |
161 | regulation of clathrin-mediated endocytosis (GO:2000369) | 2.46544820 |
162 | regulation of postsynaptic membrane potential (GO:0060078) | 2.46307046 |
163 | acidic amino acid transport (GO:0015800) | 2.46043841 |
164 | neuromuscular process controlling posture (GO:0050884) | 2.45284255 |
165 | import into cell (GO:0098657) | 2.44913923 |
166 | regulation of neurotransmitter levels (GO:0001505) | 2.43502689 |
167 | cellular potassium ion homeostasis (GO:0030007) | 2.42861760 |
168 | astrocyte differentiation (GO:0048708) | 2.42331705 |
169 | cortical actin cytoskeleton organization (GO:0030866) | 2.42163698 |
170 | creatine metabolic process (GO:0006600) | 2.41480709 |
171 | histone H3-K9 demethylation (GO:0033169) | 2.41195589 |
172 | regulation of dendritic spine morphogenesis (GO:0061001) | 2.40183390 |
173 | regulation of respiratory gaseous exchange by neurological system process (GO:0002087) | 2.40130693 |
174 | regulation of Rap GTPase activity (GO:0032317) | 2.40041512 |
175 | regulation of dendritic spine development (GO:0060998) | 2.39600328 |
176 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.39207131 |
177 | response to interleukin-15 (GO:0070672) | 2.39044849 |
178 | activation of protein kinase A activity (GO:0034199) | 2.38804336 |
179 | negative regulation of T cell mediated immunity (GO:0002710) | 2.37422613 |
180 | protein localization to cytoskeleton (GO:0044380) | 2.37356811 |
181 | negative regulation of protein oligomerization (GO:0032460) | 2.36462446 |
182 | detection of temperature stimulus involved in sensory perception of pain (GO:0050965) | 2.36142836 |
183 | detection of temperature stimulus involved in sensory perception (GO:0050961) | 2.36142836 |
184 | positive regulation of granulocyte differentiation (GO:0030854) | 2.35772914 |
185 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 2.35764533 |
186 | regulation of natural killer cell mediated immunity (GO:0002715) | 2.35764533 |
187 | acrosome reaction (GO:0007340) | 2.30190908 |
188 | detection of biotic stimulus (GO:0009595) | 2.29754878 |
189 | genetic imprinting (GO:0071514) | 2.29297325 |
190 | cellular response to interleukin-15 (GO:0071350) | 2.28683627 |
191 | positive regulation of mast cell activation (GO:0033005) | 2.28262062 |
Rank | Gene Set | Z-score |
---|---|---|
1 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.20697592 |
2 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.20572352 |
3 | EZH2_22144423_ChIP-Seq_EOC_Human | 3.14001885 |
4 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.92918645 |
5 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.61987053 |
6 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.56209800 |
7 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 2.53233583 |
8 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.52099473 |
9 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.48356693 |
10 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 2.32902518 |
11 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.30317443 |
12 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.24328216 |
13 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.16797030 |
14 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.13719058 |
15 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.09814008 |
16 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.09814008 |
17 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.05554638 |
18 | REST_21632747_ChIP-Seq_MESCs_Mouse | 2.02482433 |
19 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 2.01110004 |
20 | AR_21572438_ChIP-Seq_LNCaP_Human | 2.00311585 |
21 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.99129560 |
22 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.86912294 |
23 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.86012206 |
24 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.84008112 |
25 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.82962932 |
26 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.81925504 |
27 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.79907691 |
28 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.77330726 |
29 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.75187177 |
30 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.67465324 |
31 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.67010415 |
32 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.66516579 |
33 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.66100840 |
34 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.57115948 |
35 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.55070808 |
36 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.55033947 |
37 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.53858255 |
38 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.51417847 |
39 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.51172903 |
40 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.48707734 |
41 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.47341870 |
42 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.45355654 |
43 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.44930280 |
44 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.44732024 |
45 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.40499299 |
46 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.39913894 |
47 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.37804441 |
48 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.36663046 |
49 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.35279642 |
50 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.34766486 |
51 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.34499571 |
52 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.34329819 |
53 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.33965971 |
54 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.33527223 |
55 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.33059482 |
56 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.32507523 |
57 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.32316260 |
58 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 1.32250099 |
59 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.31377359 |
60 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.31052698 |
61 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.29745589 |
62 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.28523509 |
63 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.28234598 |
64 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.27722032 |
65 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.27513369 |
66 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.26833178 |
67 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.26518913 |
68 | GATA1_22025678_ChIP-Seq_K562_Human | 1.26065516 |
69 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.24210724 |
70 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.23667218 |
71 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.22634522 |
72 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.21956345 |
73 | SPI1_23127762_ChIP-Seq_K562_Human | 1.21841754 |
74 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.20472759 |
75 | P300_19829295_ChIP-Seq_ESCs_Human | 1.20204117 |
76 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.19916386 |
77 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.19910095 |
78 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.19750515 |
79 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.18820924 |
80 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.17902931 |
81 | STAT3_23295773_ChIP-Seq_U87_Human | 1.17406863 |
82 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.17258892 |
83 | SUZ12_18555785_Chip-Seq_ESCs_Mouse | 1.15017177 |
84 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.14624694 |
85 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 1.14315966 |
86 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 1.13902511 |
87 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.13060343 |
88 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 1.12890677 |
89 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.12035359 |
90 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.11325568 |
91 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.10710835 |
92 | P53_22387025_ChIP-Seq_ESCs_Mouse | 1.10272833 |
93 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.10189223 |
94 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.09720068 |
95 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.09279655 |
96 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.08845154 |
97 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.08845154 |
98 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.08831405 |
99 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.08446161 |
100 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.08311134 |
101 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.07701182 |
102 | SMRT_27268052_Chip-Seq_Bcells_Human | 1.07617194 |
103 | MYB_26560356_Chip-Seq_TH2_Human | 1.07512601 |
104 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 1.06899160 |
105 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.05461481 |
106 | CMYC_18555785_Chip-Seq_ESCs_Mouse | 1.04317887 |
107 | TCF4_23295773_ChIP-Seq_U87_Human | 1.04145806 |
108 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.03887610 |
109 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.03448499 |
110 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.02681380 |
111 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.01122267 |
112 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.00662391 |
113 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 1.00002082 |
114 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 0.99933571 |
115 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.99875776 |
116 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 0.99570147 |
117 | AR_25329375_ChIP-Seq_VCAP_Human | 0.99460844 |
118 | STAT3_24763339_ChIP-Seq_IMN-ESCs_Mouse | 0.98915495 |
119 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.98188011 |
120 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 0.98188011 |
121 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 0.97802696 |
122 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.97800678 |
123 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 0.97724190 |
124 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.96365063 |
125 | TAL1_21186366_ChIP-Seq_BM-HSCs_Mouse | 0.96309570 |
126 | TCF4_22108803_ChIP-Seq_LS180_Human | 0.95732266 |
127 | KDM2B_26808549_Chip-Seq_K562_Human | 0.94505728 |
128 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 0.94096389 |
129 | EBF1_22473956_ChIP-Seq_LYMPHODE_Mouse | 0.94030128 |
130 | SOX2_18555785_Chip-Seq_ESCs_Mouse | 0.94027674 |
131 | AR_19668381_ChIP-Seq_PC3_Human | 0.92895310 |
132 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 0.92372662 |
133 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 0.92228971 |
134 | TP53_16413492_ChIP-PET_HCT116_Human | 0.91857153 |
135 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.91335116 |
136 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.91335116 |
137 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 0.90422328 |
138 | LMO2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.89692134 |
139 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 0.88770116 |
140 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 0.88713170 |
141 | RUNX2_22187159_ChIP-Seq_PCA_Human | 0.88355601 |
142 | SMAD3_21741376_ChIP-Seq_ESCs_Human | 0.87615134 |
143 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.87281466 |
144 | VDR_24787735_ChIP-Seq_THP-1_Human | 0.86948298 |
145 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.84642343 |
146 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.83885419 |
147 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.82713749 |
148 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 0.82156268 |
149 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 0.81866324 |
150 | GATA1_19941826_ChIP-Seq_K562_Human | 0.81830250 |
151 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.81218407 |
152 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.81184706 |
153 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 0.80070621 |
154 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.79385580 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0004859_abnormal_synaptic_plasticity | 4.79865392 |
2 | MP0003880_abnormal_central_pattern | 4.64035247 |
3 | MP0000920_abnormal_myelination | 3.67520195 |
4 | MP0008877_abnormal_DNA_methylation | 3.49179440 |
5 | MP0003635_abnormal_synaptic_transmissio | 3.31212782 |
6 | MP0002064_seizures | 3.19727520 |
7 | MP0004270_analgesia | 3.18394420 |
8 | MP0003690_abnormal_glial_cell | 3.05029990 |
9 | MP0009745_abnormal_behavioral_response | 2.92349147 |
10 | MP0003329_amyloid_beta_deposits | 2.76882764 |
11 | MP0003724_increased_susceptibility_to | 2.71938296 |
12 | MP0002272_abnormal_nervous_system | 2.67516607 |
13 | MP0001835_abnormal_antigen_presentation | 2.67040254 |
14 | MP0001486_abnormal_startle_reflex | 2.66847249 |
15 | MP0005423_abnormal_somatic_nervous | 2.65210352 |
16 | MP0009046_muscle_twitch | 2.64509993 |
17 | MP0002063_abnormal_learning/memory/cond | 2.54475975 |
18 | MP0004885_abnormal_endolymph | 2.39762091 |
19 | MP0005671_abnormal_response_to | 2.35815517 |
20 | MP0002572_abnormal_emotion/affect_behav | 2.32169377 |
21 | MP0008057_abnormal_DNA_replication | 2.27632538 |
22 | MP0002822_catalepsy | 2.27108921 |
23 | MP0001968_abnormal_touch/_nociception | 2.24854715 |
24 | MP0001529_abnormal_vocalization | 2.24293641 |
25 | MP0003122_maternal_imprinting | 2.22442419 |
26 | MP0001905_abnormal_dopamine_level | 2.21637026 |
27 | MP0003195_calcinosis | 2.14360077 |
28 | MP0003300_gastrointestinal_ulcer | 2.10057558 |
29 | MP0003172_abnormal_lysosome_physiology | 2.04121635 |
30 | MP0003634_abnormal_glial_cell | 2.01806089 |
31 | MP0002734_abnormal_mechanical_nocicepti | 1.98210551 |
32 | MP0005058_abnormal_lysosome_morphology | 1.97758891 |
33 | MP0008569_lethality_at_weaning | 1.95895246 |
34 | MP0000685_abnormal_immune_system | 1.95002844 |
35 | MP0001440_abnormal_grooming_behavior | 1.94939946 |
36 | MP0000604_amyloidosis | 1.94516318 |
37 | MP0001800_abnormal_humoral_immune | 1.93234168 |
38 | MP0002736_abnormal_nociception_after | 1.86851919 |
39 | MP0004742_abnormal_vestibular_system | 1.84373029 |
40 | MP0000778_abnormal_nervous_system | 1.83450292 |
41 | MP0002067_abnormal_sensory_capabilities | 1.80506101 |
42 | MP0001970_abnormal_pain_threshold | 1.76979056 |
43 | MP0003633_abnormal_nervous_system | 1.75894759 |
44 | MP0002735_abnormal_chemical_nociception | 1.75080479 |
45 | MP0004142_abnormal_muscle_tone | 1.74961239 |
46 | MP0001501_abnormal_sleep_pattern | 1.74669220 |
47 | MP0002733_abnormal_thermal_nociception | 1.73905684 |
48 | MP0005386_behavior/neurological_phenoty | 1.68427653 |
49 | MP0004924_abnormal_behavior | 1.68427653 |
50 | MP0003121_genomic_imprinting | 1.67569866 |
51 | MP0009785_altered_susceptibility_to | 1.66295872 |
52 | MP0005025_abnormal_response_to | 1.64718767 |
53 | MP0002229_neurodegeneration | 1.62921567 |
54 | MP0003632_abnormal_nervous_system | 1.62529057 |
55 | MP0003631_nervous_system_phenotype | 1.61927072 |
56 | MP0005409_darkened_coat_color | 1.54185506 |
57 | MP0002723_abnormal_immune_serum | 1.52795726 |
58 | MP0001986_abnormal_taste_sensitivity | 1.50955249 |
59 | MP0002420_abnormal_adaptive_immunity | 1.45681716 |
60 | MP0003045_fibrosis | 1.45657451 |
61 | MP0002066_abnormal_motor_capabilities/c | 1.43881491 |
62 | MP0003436_decreased_susceptibility_to | 1.43057624 |
63 | MP0001819_abnormal_immune_cell | 1.41980601 |
64 | MP0002452_abnormal_antigen_presenting | 1.41683954 |
65 | MP0000955_abnormal_spinal_cord | 1.41433250 |
66 | MP0003183_abnormal_peptide_metabolism | 1.37769385 |
67 | MP0002882_abnormal_neuron_morphology | 1.35859498 |
68 | MP0002405_respiratory_system_inflammati | 1.31402413 |
69 | MP0004811_abnormal_neuron_physiology | 1.29371533 |
70 | MP0002557_abnormal_social/conspecific_i | 1.25336344 |
71 | MP0003828_pulmonary_edema | 1.24973716 |
72 | MP0003075_altered_response_to | 1.18200864 |
73 | MP0000015_abnormal_ear_pigmentation | 1.17351489 |
74 | MP0004883_abnormal_blood_vessel | 1.16685499 |
75 | MP0009780_abnormal_chondrocyte_physiolo | 1.16657534 |
76 | MP0005645_abnormal_hypothalamus_physiol | 1.16444005 |
77 | MP0008874_decreased_physiological_sensi | 1.14735175 |
78 | MP0003252_abnormal_bile_duct | 1.14439397 |
79 | MP0004858_abnormal_nervous_system | 1.14321374 |
80 | MP0002090_abnormal_vision | 1.13257629 |
81 | MP0005646_abnormal_pituitary_gland | 1.13113683 |
82 | MP0000716_abnormal_immune_system | 1.11628846 |
83 | MP0003303_peritoneal_inflammation | 1.11599908 |
84 | MP0002184_abnormal_innervation | 1.11373852 |
85 | MP0005174_abnormal_tail_pigmentation | 1.09568002 |
86 | MP0002398_abnormal_bone_marrow | 1.07567982 |
87 | MP0001984_abnormal_olfaction | 1.07258036 |
88 | MP0005171_absent_coat_pigmentation | 1.07182073 |
89 | MP0003763_abnormal_thymus_physiology | 1.05672860 |
90 | MP0002876_abnormal_thyroid_physiology | 1.05366125 |
91 | MP0005310_abnormal_salivary_gland | 1.04842991 |
92 | MP0002148_abnormal_hypersensitivity_rea | 1.04186762 |
93 | MP0003866_abnormal_defecation | 1.01081648 |
94 | MP0000689_abnormal_spleen_morphology | 1.00987800 |
95 | MP0001485_abnormal_pinna_reflex | 1.00416888 |
96 | MP0002693_abnormal_pancreas_physiology | 1.00048148 |
97 | MP0001963_abnormal_hearing_physiology | 0.99707783 |
98 | MP0010155_abnormal_intestine_physiology | 0.98838505 |
99 | MP0010234_abnormal_vibrissa_follicle | 0.98002097 |
100 | MP0002152_abnormal_brain_morphology | 0.96455489 |
101 | MP0000383_abnormal_hair_follicle | 0.95796419 |
102 | MP0001845_abnormal_inflammatory_respons | 0.95612092 |
103 | MP0003787_abnormal_imprinting | 0.94389496 |
104 | MP0005551_abnormal_eye_electrophysiolog | 0.94114290 |
105 | MP0001533_abnormal_skeleton_physiology | 0.94079111 |
106 | MP0002277_abnormal_respiratory_mucosa | 0.93796626 |
107 | MP0001502_abnormal_circadian_rhythm | 0.93787222 |
108 | MP0006276_abnormal_autonomic_nervous | 0.93160130 |
109 | MP0000465_gastrointestinal_hemorrhage | 0.91610976 |
110 | MP0000569_abnormal_digit_pigmentation | 0.90924771 |
111 | MP0004043_abnormal_pH_regulation | 0.90282960 |
112 | MP0001851_eye_inflammation | 0.89883944 |
113 | MP0002928_abnormal_bile_duct | 0.87757581 |
114 | MP0001177_atelectasis | 0.84324751 |
115 | MP0005075_abnormal_melanosome_morpholog | 0.83266266 |
116 | MP0003879_abnormal_hair_cell | 0.81931234 |
117 | MP0002168_other_aberrant_phenotype | 0.81586840 |
118 | MP0003656_abnormal_erythrocyte_physiolo | 0.80368804 |
119 | MP0002069_abnormal_eating/drinking_beha | 0.80257416 |
120 | MP0002722_abnormal_immune_system | 0.79168153 |
121 | MP0009764_decreased_sensitivity_to | 0.77966466 |
122 | MP0010329_abnormal_lipoprotein_level | 0.77945361 |
123 | MP0009765_abnormal_xenobiotic_induced | 0.77904939 |
124 | MP0002909_abnormal_adrenal_gland | 0.77425073 |
125 | MP0005365_abnormal_bile_salt | 0.77278954 |
126 | MP0005535_abnormal_body_temperature | 0.77135004 |
127 | MP0001188_hyperpigmentation | 0.76946785 |
128 | MP0004510_myositis | 0.74745661 |
129 | MP0006082_CNS_inflammation | 0.74128044 |
130 | MP0000747_muscle_weakness | 0.71065199 |
131 | MP0002752_abnormal_somatic_nervous | 0.70567246 |
132 | MP0005167_abnormal_blood-brain_barrier | 0.69248777 |
133 | MP0010386_abnormal_urinary_bladder | 0.68137579 |
134 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.68045009 |
135 | MP0005623_abnormal_meninges_morphology | 0.66866774 |
136 | MP0001661_extended_life_span | 0.65980933 |
137 | MP0008872_abnormal_physiological_respon | 0.65531907 |
138 | MP0010678_abnormal_skin_adnexa | 0.65060974 |
139 | MP0004134_abnormal_chest_morphology | 0.62864001 |
140 | MP0001790_abnormal_immune_system | 0.59250429 |
141 | MP0005387_immune_system_phenotype | 0.59250429 |
142 | MP0005000_abnormal_immune_tolerance | 0.55588305 |
143 | MP0009840_abnormal_foam_cell | 0.55234318 |
144 | MP0004147_increased_porphyrin_level | 0.55221987 |
145 | MP0000639_abnormal_adrenal_gland | 0.55173087 |
146 | MP0002419_abnormal_innate_immunity | 0.54486279 |
147 | MP0001765_abnormal_ion_homeostasis | 0.53886041 |
148 | MP0008260_abnormal_autophagy | 0.52560248 |
149 | MP0001943_abnormal_respiration | 0.49908747 |
150 | MP0001299_abnormal_eye_distance/ | 0.49459399 |
151 | MP0003136_yellow_coat_color | 0.49308866 |
152 | MP0005464_abnormal_platelet_physiology | 0.48445111 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Neurofibrillary tangles (HP:0002185) | 5.56942378 |
2 | Myokymia (HP:0002411) | 4.97837191 |
3 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 4.64611762 |
4 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 4.64611762 |
5 | Supranuclear gaze palsy (HP:0000605) | 4.54284051 |
6 | Cerebral inclusion bodies (HP:0100314) | 4.54264271 |
7 | Volvulus (HP:0002580) | 4.43296134 |
8 | Focal motor seizures (HP:0011153) | 4.29800766 |
9 | Recurrent bacterial skin infections (HP:0005406) | 4.06089261 |
10 | Abnormality of the corticospinal tract (HP:0002492) | 3.99073579 |
11 | Papillary thyroid carcinoma (HP:0002895) | 3.81043293 |
12 | Recurrent abscess formation (HP:0002722) | 3.74609962 |
13 | Intention tremor (HP:0002080) | 3.73936966 |
14 | Spastic gait (HP:0002064) | 3.61883731 |
15 | Dysmetria (HP:0001310) | 3.53952304 |
16 | Peripheral hypomyelination (HP:0007182) | 3.52636254 |
17 | Eczematoid dermatitis (HP:0000976) | 3.50702018 |
18 | Focal seizures (HP:0007359) | 3.45229711 |
19 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 3.33344145 |
20 | Atonic seizures (HP:0010819) | 3.30087470 |
21 | Insidious onset (HP:0003587) | 3.27271089 |
22 | Termporal pattern (HP:0011008) | 3.27271089 |
23 | Constricted visual fields (HP:0001133) | 3.24643876 |
24 | Onion bulb formation (HP:0003383) | 3.20455931 |
25 | Sensory axonal neuropathy (HP:0003390) | 3.18696249 |
26 | Visual hallucinations (HP:0002367) | 3.17697294 |
27 | Abnormality of macrophages (HP:0004311) | 3.13150556 |
28 | Ankle clonus (HP:0011448) | 3.12496186 |
29 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.09142331 |
30 | Mutism (HP:0002300) | 3.02097381 |
31 | Increased cerebral lipofuscin (HP:0011813) | 3.01637257 |
32 | Action tremor (HP:0002345) | 2.98490218 |
33 | Retrobulbar optic neuritis (HP:0100654) | 2.93228603 |
34 | Optic neuritis (HP:0100653) | 2.93228603 |
35 | Gingival bleeding (HP:0000225) | 2.92466092 |
36 | T lymphocytopenia (HP:0005403) | 2.90549540 |
37 | Recurrent fungal infections (HP:0002841) | 2.88638329 |
38 | Akinesia (HP:0002304) | 2.85431851 |
39 | Thyroiditis (HP:0100646) | 2.85021693 |
40 | Truncal obesity (HP:0001956) | 2.84939755 |
41 | Neuronal loss in central nervous system (HP:0002529) | 2.82731434 |
42 | Increased circulating renin level (HP:0000848) | 2.81885055 |
43 | Genetic anticipation (HP:0003743) | 2.81464575 |
44 | Spastic tetraparesis (HP:0001285) | 2.81234967 |
45 | Abnormal eating behavior (HP:0100738) | 2.79603833 |
46 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.77984694 |
47 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.76766343 |
48 | Stomatitis (HP:0010280) | 2.74667455 |
49 | Abnormality of T cell number (HP:0011839) | 2.74565249 |
50 | Recurrent skin infections (HP:0001581) | 2.72324427 |
51 | Postural instability (HP:0002172) | 2.70208129 |
52 | Hyperventilation (HP:0002883) | 2.66489770 |
53 | Orchitis (HP:0100796) | 2.64564040 |
54 | Epileptic encephalopathy (HP:0200134) | 2.63237345 |
55 | Scanning speech (HP:0002168) | 2.63041862 |
56 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.61713891 |
57 | Recurrent cutaneous fungal infections (HP:0011370) | 2.61713891 |
58 | Urinary bladder sphincter dysfunction (HP:0002839) | 2.58304217 |
59 | Abnormality of binocular vision (HP:0011514) | 2.57260441 |
60 | Diplopia (HP:0000651) | 2.57260441 |
61 | Thyroid carcinoma (HP:0002890) | 2.56375638 |
62 | Spontaneous hematomas (HP:0007420) | 2.54785001 |
63 | Progressive cerebellar ataxia (HP:0002073) | 2.54368028 |
64 | Meningitis (HP:0001287) | 2.53049209 |
65 | Abnormal auditory evoked potentials (HP:0006958) | 2.52691233 |
66 | Myositis (HP:0100614) | 2.52300582 |
67 | Pheochromocytoma (HP:0002666) | 2.51460408 |
68 | Broad-based gait (HP:0002136) | 2.49928147 |
69 | Neoplasm of the tracheobronchial system (HP:0100552) | 2.47713929 |
70 | Cerebral hypomyelination (HP:0006808) | 2.46908949 |
71 | Metabolic alkalosis (HP:0200114) | 2.43490639 |
72 | Polyphagia (HP:0002591) | 2.40572088 |
73 | Urinary urgency (HP:0000012) | 2.37047006 |
74 | Limb dystonia (HP:0002451) | 2.36415079 |
75 | Dialeptic seizures (HP:0011146) | 2.36197430 |
76 | Absence seizures (HP:0002121) | 2.35739662 |
77 | Dysdiadochokinesis (HP:0002075) | 2.35516942 |
78 | Severe combined immunodeficiency (HP:0004430) | 2.34895184 |
79 | Generalized tonic-clonic seizures (HP:0002069) | 2.32521476 |
80 | Loss of speech (HP:0002371) | 2.31956633 |
81 | Clumsiness (HP:0002312) | 2.30718602 |
82 | Abnormality of eosinophils (HP:0001879) | 2.29978289 |
83 | Lower limb muscle weakness (HP:0007340) | 2.29609936 |
84 | Truncal ataxia (HP:0002078) | 2.29555976 |
85 | Parakeratosis (HP:0001036) | 2.29542933 |
86 | Anxiety (HP:0000739) | 2.28280196 |
87 | Hypokalemic alkalosis (HP:0001949) | 2.27801794 |
88 | Hypochromic microcytic anemia (HP:0004840) | 2.25034275 |
89 | Leukocytosis (HP:0001974) | 2.24757575 |
90 | Excessive salivation (HP:0003781) | 2.23855098 |
91 | Drooling (HP:0002307) | 2.23855098 |
92 | Slow saccadic eye movements (HP:0000514) | 2.23504186 |
93 | Macroorchidism (HP:0000053) | 2.23360239 |
94 | Progressive inability to walk (HP:0002505) | 2.22220868 |
95 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.21366130 |
96 | Vasculitis (HP:0002633) | 2.21043038 |
97 | Amyotrophic lateral sclerosis (HP:0007354) | 2.18596234 |
98 | Depression (HP:0000716) | 2.16192926 |
99 | Psychosis (HP:0000709) | 2.16081029 |
100 | Mediastinal lymphadenopathy (HP:0100721) | 2.15635154 |
101 | Panhypogammaglobulinemia (HP:0003139) | 2.15596536 |
102 | Gastrointestinal infarctions (HP:0005244) | 2.14033454 |
103 | Axonal loss (HP:0003447) | 2.13969326 |
104 | Keratoconjunctivitis (HP:0001096) | 2.12438820 |
105 | Hypoplasia of the thymus (HP:0000778) | 2.12300225 |
106 | Impaired vibratory sensation (HP:0002495) | 2.12291088 |
107 | Clonus (HP:0002169) | 2.09641409 |
108 | Impaired vibration sensation in the lower limbs (HP:0002166) | 2.08760323 |
109 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.08413702 |
110 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.08413702 |
111 | Abnormality of glycolipid metabolism (HP:0010969) | 2.08413702 |
112 | Dysostosis multiplex (HP:0000943) | 2.08148698 |
113 | Toxemia of pregnancy (HP:0100603) | 2.08132071 |
114 | Febrile seizures (HP:0002373) | 2.07169184 |
115 | Papilledema (HP:0001085) | 2.06911999 |
116 | Widely spaced teeth (HP:0000687) | 2.05270775 |
117 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 2.04933114 |
118 | Neuroendocrine neoplasm (HP:0100634) | 2.04379229 |
119 | Systemic lupus erythematosus (HP:0002725) | 2.04277918 |
120 | Gingivitis (HP:0000230) | 2.04078424 |
121 | Gaze-evoked nystagmus (HP:0000640) | 2.03565117 |
122 | Generalized myoclonic seizures (HP:0002123) | 2.02658297 |
123 | Keratoconjunctivitis sicca (HP:0001097) | 2.02552348 |
124 | Torticollis (HP:0000473) | 1.98209017 |
125 | Hemoptysis (HP:0002105) | 1.98044296 |
126 | Bowel incontinence (HP:0002607) | 1.97702164 |
127 | Cerebral hemorrhage (HP:0001342) | 1.97696836 |
128 | Abnormality of saccadic eye movements (HP:0000570) | 1.96887240 |
129 | Peripheral demyelination (HP:0011096) | 1.96562803 |
130 | Prolonged bleeding time (HP:0003010) | 1.96326751 |
131 | Recurrent bronchitis (HP:0002837) | 1.95076824 |
132 | Polygenic inheritance (HP:0010982) | 1.94015862 |
133 | Rigidity (HP:0002063) | 1.93373045 |
134 | Urinary incontinence (HP:0000020) | 1.92871091 |
135 | Chest pain (HP:0100749) | 1.92852737 |
136 | Blue irides (HP:0000635) | 1.91386284 |
137 | Pulmonary infiltrates (HP:0002113) | 1.89568469 |
138 | Segmental peripheral demyelination/remyelination (HP:0003481) | 1.89106283 |
139 | Apathy (HP:0000741) | 1.88927399 |
140 | Elevated erythrocyte sedimentation rate (HP:0003565) | 1.88166071 |
141 | CNS hypomyelination (HP:0003429) | 1.87772482 |
142 | Abnormality of T cells (HP:0002843) | 1.87691825 |
143 | Limb hypertonia (HP:0002509) | 1.87615243 |
144 | Abnormal hair whorl (HP:0010721) | 1.86907246 |
145 | Autoimmune thrombocytopenia (HP:0001973) | 1.86845020 |
146 | Pulmonary embolism (HP:0002204) | 1.86213518 |
147 | Abnormal large intestine physiology (HP:0012700) | 1.85341080 |
148 | Epistaxis (HP:0000421) | 1.84844289 |
149 | Thickened calvaria (HP:0002684) | 1.81967466 |
150 | Disinhibition (HP:0000734) | 1.81813105 |
151 | Rhabdomyosarcoma (HP:0002859) | 1.81735377 |
152 | Megalencephaly (HP:0001355) | 1.81103644 |
153 | Alacrima (HP:0000522) | 1.81086189 |
154 | Agnosia (HP:0010524) | 1.81008346 |
155 | Intrahepatic cholestasis (HP:0001406) | 1.80873131 |
156 | Hemiplegia (HP:0002301) | 1.80195028 |
157 | Chronic obstructive pulmonary disease (HP:0006510) | 1.79179557 |
158 | Obstructive lung disease (HP:0006536) | 1.79179557 |
159 | Rapidly progressive (HP:0003678) | 1.78843657 |
160 | Amyloidosis (HP:0011034) | 1.78383362 |
161 | Episodic fever (HP:0001954) | 1.77668471 |
162 | Urticaria (HP:0001025) | 1.77319597 |
163 | Low anterior hairline (HP:0000294) | 1.75941936 |
164 | Abnormality of the fingertips (HP:0001211) | 1.75355233 |
165 | Arterial tortuosity (HP:0005116) | 1.75008913 |
166 | Hypomagnesemia (HP:0002917) | 1.74642380 |
167 | Encephalitis (HP:0002383) | 1.74467767 |
168 | Morphological abnormality of the pyramidal tract (HP:0002062) | 1.73655350 |
169 | Abnormality of the prostate (HP:0008775) | 1.73517446 |
170 | Abnormality of salivation (HP:0100755) | 1.72648444 |
171 | Sepsis (HP:0100806) | 1.72424808 |
172 | Agitation (HP:0000713) | 1.71824492 |
173 | Partial agenesis of the corpus callosum (HP:0001338) | 1.71516574 |
174 | Lymphopenia (HP:0001888) | 1.69884840 |
175 | Eosinophilia (HP:0001880) | 1.69322720 |
176 | Combined immunodeficiency (HP:0005387) | 1.68329126 |
177 | Arterial thrombosis (HP:0004420) | 1.65191789 |
178 | Abnormality of B cell number (HP:0010975) | 1.65042757 |
179 | Agammaglobulinemia (HP:0004432) | 1.59951338 |
180 | Peritonitis (HP:0002586) | 1.59411421 |
Rank | Gene Set | Z-score |
---|---|---|
1 | OXSR1 | 3.44901770 |
2 | STK39 | 3.26485386 |
3 | EPHA4 | 2.64635245 |
4 | MAP3K9 | 2.34820402 |
5 | NTRK3 | 2.23787827 |
6 | TAF1 | 2.22114401 |
7 | EPHB1 | 2.16619322 |
8 | RIPK4 | 2.13424317 |
9 | PRPF4B | 2.10529349 |
10 | FES | 2.09408834 |
11 | NTRK1 | 1.86664119 |
12 | PKN1 | 1.86271794 |
13 | CDK19 | 1.85263754 |
14 | TNIK | 1.81856661 |
15 | FGFR2 | 1.76656615 |
16 | MAP3K4 | 1.75565695 |
17 | MARK1 | 1.73453805 |
18 | TYRO3 | 1.68514749 |
19 | PIK3CG | 1.68500790 |
20 | PAK6 | 1.66125352 |
21 | SGK2 | 1.64168008 |
22 | FGR | 1.54899703 |
23 | MATK | 1.54159096 |
24 | CASK | 1.49635051 |
25 | MAP3K13 | 1.46715380 |
26 | TEC | 1.44747761 |
27 | UHMK1 | 1.44064237 |
28 | TRPM7 | 1.43937456 |
29 | MAPKAPK5 | 1.43906725 |
30 | PNCK | 1.42443261 |
31 | MINK1 | 1.40490685 |
32 | WNK1 | 1.40199553 |
33 | FRK | 1.35575968 |
34 | CDK5 | 1.35501261 |
35 | ARAF | 1.32510399 |
36 | TYK2 | 1.30553610 |
37 | NTRK2 | 1.29855240 |
38 | SGK494 | 1.29764052 |
39 | SGK223 | 1.29764052 |
40 | SGK3 | 1.29634293 |
41 | KSR2 | 1.29513655 |
42 | WNK4 | 1.24053051 |
43 | DAPK2 | 1.23782611 |
44 | ITK | 1.20026565 |
45 | GRK7 | 1.17628310 |
46 | BMPR2 | 1.17089863 |
47 | TXK | 1.16073871 |
48 | CSNK1G2 | 1.15774403 |
49 | ROCK2 | 1.14809162 |
50 | CAMK1G | 1.13206861 |
51 | NEK6 | 1.09385531 |
52 | CSNK1G3 | 1.08617610 |
53 | MAP3K2 | 1.07976291 |
54 | BTK | 1.07946173 |
55 | MAPK13 | 1.07869740 |
56 | CLK1 | 1.05892321 |
57 | CAMK2B | 1.05082742 |
58 | SIK2 | 1.04417954 |
59 | PAK3 | 1.03335972 |
60 | YES1 | 1.03102567 |
61 | CAMKK1 | 1.02511617 |
62 | IRAK4 | 1.02085691 |
63 | KIT | 1.00355074 |
64 | MAP3K14 | 0.98963205 |
65 | PDPK1 | 0.97329346 |
66 | PDK1 | 0.96620185 |
67 | FGFR3 | 0.96132790 |
68 | PRKCH | 0.94901697 |
69 | MAP3K12 | 0.94627246 |
70 | STK11 | 0.91753197 |
71 | BMPR1B | 0.91280232 |
72 | MARK2 | 0.91112165 |
73 | MAP4K1 | 0.89819960 |
74 | MET | 0.88411124 |
75 | FYN | 0.88372526 |
76 | KSR1 | 0.88202227 |
77 | MAP2K4 | 0.87893478 |
78 | IKBKE | 0.86542046 |
79 | PRKCQ | 0.86408290 |
80 | NLK | 0.85881512 |
81 | CDK14 | 0.85721489 |
82 | CDK15 | 0.83817754 |
83 | RET | 0.83397857 |
84 | MAPK15 | 0.82827513 |
85 | CDK18 | 0.79523004 |
86 | PLK2 | 0.78972020 |
87 | JAK2 | 0.78173637 |
88 | CSNK1A1L | 0.78085449 |
89 | NEK9 | 0.77946184 |
90 | LIMK1 | 0.76919786 |
91 | GRK5 | 0.74942861 |
92 | CAMK2A | 0.74931581 |
93 | LYN | 0.74812512 |
94 | CSNK1G1 | 0.74421711 |
95 | MAP2K7 | 0.73875678 |
96 | JAK1 | 0.73772594 |
97 | CDK11A | 0.73118837 |
98 | ICK | 0.72778857 |
99 | CSF1R | 0.71908477 |
100 | RAF1 | 0.70776513 |
101 | TNK2 | 0.69912453 |
102 | CAMK2D | 0.69082059 |
103 | MAP3K1 | 0.67170267 |
104 | PHKG2 | 0.66979449 |
105 | PHKG1 | 0.66979449 |
106 | PTK2B | 0.66607763 |
107 | MAP3K10 | 0.66422236 |
108 | TAOK3 | 0.66377880 |
109 | MAP2K3 | 0.60848657 |
110 | PDGFRB | 0.60720989 |
111 | BCR | 0.60646676 |
112 | CSK | 0.59951985 |
113 | GRK6 | 0.59749778 |
114 | CDK9 | 0.58304174 |
115 | HCK | 0.58173013 |
116 | BRAF | 0.57828289 |
117 | PRKD1 | 0.57700333 |
118 | JAK3 | 0.56923833 |
119 | CAMK2G | 0.56741730 |
120 | ZAP70 | 0.56059764 |
121 | STK38 | 0.54903646 |
122 | PRKCG | 0.54715494 |
123 | BLK | 0.53543336 |
124 | TESK2 | 0.51982365 |
125 | SGK1 | 0.51814808 |
126 | ALK | 0.51025585 |
127 | HIPK2 | 0.49578790 |
128 | CAMKK2 | 0.48578692 |
129 | DYRK1A | 0.48528217 |
130 | CDC42BPA | 0.47676366 |
131 | BMX | 0.47658526 |
132 | ADRBK2 | 0.47460632 |
133 | MAP3K7 | 0.47189060 |
134 | LCK | 0.45772537 |
135 | SYK | 0.44923186 |
136 | PRKCE | 0.44810208 |
137 | CSNK1D | 0.44158462 |
138 | PRKCZ | 0.43095701 |
139 | ACVR1B | 0.42708549 |
140 | CAMK1D | 0.42383450 |
141 | ABL1 | 0.40928123 |
142 | CAMK4 | 0.40543070 |
143 | PRKG1 | 0.39889836 |
144 | ERBB2 | 0.39045329 |
145 | PINK1 | 0.37583917 |
146 | RPS6KB1 | 0.35443814 |
147 | AKT3 | 0.33061302 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 2.48572918 |
2 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 2.15824648 |
3 | GABAergic synapse_Homo sapiens_hsa04727 | 2.15688452 |
4 | Leishmaniasis_Homo sapiens_hsa05140 | 2.14138170 |
5 | Nicotine addiction_Homo sapiens_hsa05033 | 2.10651242 |
6 | Glutamatergic synapse_Homo sapiens_hsa04724 | 2.09955264 |
7 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 2.08762656 |
8 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 1.96800964 |
9 | Morphine addiction_Homo sapiens_hsa05032 | 1.96008713 |
10 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.92744490 |
11 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.90985772 |
12 | Olfactory transduction_Homo sapiens_hsa04740 | 1.90560639 |
13 | Allograft rejection_Homo sapiens_hsa05330 | 1.89526999 |
14 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.85414888 |
15 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.83862497 |
16 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.79058595 |
17 | Circadian entrainment_Homo sapiens_hsa04713 | 1.78434859 |
18 | Long-term potentiation_Homo sapiens_hsa04720 | 1.67424130 |
19 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.64642915 |
20 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.62544432 |
21 | Salivary secretion_Homo sapiens_hsa04970 | 1.61181180 |
22 | Long-term depression_Homo sapiens_hsa04730 | 1.58870179 |
23 | Amphetamine addiction_Homo sapiens_hsa05031 | 1.55941509 |
24 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.55188475 |
25 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.53641273 |
26 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.47718471 |
27 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.46856529 |
28 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.44773257 |
29 | Cocaine addiction_Homo sapiens_hsa05030 | 1.44107900 |
30 | Axon guidance_Homo sapiens_hsa04360 | 1.37425733 |
31 | Ether lipid metabolism_Homo sapiens_hsa00565 | 1.37389625 |
32 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.37140507 |
33 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.35823131 |
34 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.35095686 |
35 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.35039038 |
36 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.31791330 |
37 | Renin secretion_Homo sapiens_hsa04924 | 1.31528678 |
38 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 1.28206460 |
39 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.27948010 |
40 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.26502414 |
41 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 1.25896948 |
42 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.25274124 |
43 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.20417966 |
44 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.18730233 |
45 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.18650114 |
46 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.17305210 |
47 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.14999738 |
48 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.14570686 |
49 | Lysosome_Homo sapiens_hsa04142 | 1.13417889 |
50 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.13118812 |
51 | Renal cell carcinoma_Homo sapiens_hsa05211 | 1.12085657 |
52 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.11046633 |
53 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.10768333 |
54 | Malaria_Homo sapiens_hsa05144 | 1.10634465 |
55 | ErbB signaling pathway_Homo sapiens_hsa04012 | 1.10123817 |
56 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.09698896 |
57 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 1.09413515 |
58 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.09129793 |
59 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.07948938 |
60 | Gap junction_Homo sapiens_hsa04540 | 1.04910611 |
61 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.04281972 |
62 | Insulin secretion_Homo sapiens_hsa04911 | 1.03943864 |
63 | Measles_Homo sapiens_hsa05162 | 1.03628598 |
64 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.03509623 |
65 | Asthma_Homo sapiens_hsa05310 | 1.02831976 |
66 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 1.00706760 |
67 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.99586714 |
68 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.99562623 |
69 | Endocytosis_Homo sapiens_hsa04144 | 0.98799266 |
70 | Taste transduction_Homo sapiens_hsa04742 | 0.98305577 |
71 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.98065587 |
72 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.95968638 |
73 | Glioma_Homo sapiens_hsa05214 | 0.95399445 |
74 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.94554749 |
75 | Endometrial cancer_Homo sapiens_hsa05213 | 0.92208523 |
76 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.91875592 |
77 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.91865600 |
78 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.89556198 |
79 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.88892148 |
80 | Legionellosis_Homo sapiens_hsa05134 | 0.88872496 |
81 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.88093583 |
82 | Influenza A_Homo sapiens_hsa05164 | 0.87593776 |
83 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.87083781 |
84 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.85131495 |
85 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.84994669 |
86 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.81588599 |
87 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.80591420 |
88 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.80329856 |
89 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.76871800 |
90 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.76855948 |
91 | ABC transporters_Homo sapiens_hsa02010 | 0.76431380 |
92 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.76190902 |
93 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.75025508 |
94 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.74943714 |
95 | Phagosome_Homo sapiens_hsa04145 | 0.74465032 |
96 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.73447571 |
97 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.72018938 |
98 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.71966959 |
99 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.71614948 |
100 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.70758242 |
101 | Prion diseases_Homo sapiens_hsa05020 | 0.70412026 |
102 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.69894024 |
103 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.69724858 |
104 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.68763451 |
105 | Hepatitis C_Homo sapiens_hsa05160 | 0.68755600 |
106 | Viral myocarditis_Homo sapiens_hsa05416 | 0.68141454 |
107 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.67753630 |
108 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.67502311 |
109 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.66874596 |
110 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.65930368 |
111 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.64986752 |
112 | Other glycan degradation_Homo sapiens_hsa00511 | 0.63515657 |
113 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.62290697 |
114 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.61081146 |
115 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.60945507 |
116 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.59885628 |
117 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.57558145 |
118 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.56774499 |
119 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.56615055 |
120 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.54355379 |
121 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.54248980 |
122 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.54182201 |
123 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.54178689 |
124 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.53923598 |
125 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.53800379 |
126 | Insulin resistance_Homo sapiens_hsa04931 | 0.53441891 |
127 | Platelet activation_Homo sapiens_hsa04611 | 0.53059111 |
128 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.52864118 |
129 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.46101244 |
130 | Bile secretion_Homo sapiens_hsa04976 | 0.45929679 |
131 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.41278004 |
132 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.40731859 |
133 | Melanogenesis_Homo sapiens_hsa04916 | 0.38999747 |
134 | Salmonella infection_Homo sapiens_hsa05132 | 0.37660669 |
135 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.36955577 |
136 | Tuberculosis_Homo sapiens_hsa05152 | 0.35322867 |
137 | Pertussis_Homo sapiens_hsa05133 | 0.34684747 |